A 2022 multicenter retrospective cohort study in Hong Kong, China, by Ho et al., reported a marked increase in anti-MDA5+ DM-related RP-ILD from October to December, with further analysis implicating infections as a contributing factor to the development of RP-ILD (13). This evidence concerns the gene IFIH1 and interstitial lung disease.